(Q74043108)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412684%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

review article

1 reference

title

[Prevalence and clinical significance of hepatitis C virus infection in systemic autoimmune diseases] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412684%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

2

J Font

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412684%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

3

M Ingelmo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412684%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1

M Ramos-Casals

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412684%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

publication date

1 May 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412684%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412684%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412684%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412684%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

701-709

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412684%20AND%20SRC:MED&resulttype=core&format=json

Hepatitis C virus in patients with cryoglobulinemia type II.

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Antineutrophil cytoplasmic antibodies in primary Sjögren's syndrome: prevalence and clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Primary Sjögren's syndrome and lymphatic proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Young onset of primary Sjögren's syndrome: clinical and immunological characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Primary Sjögren's syndrome in the elderly: clinical and immunological characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Primary Sjögren's syndrome in men: clinical and immunological characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Cytopenia and past human parvovirus B19 infection in patients with primary Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Hepatitis G virus infection in primary Sjögren's syndrome: analysis in a series of 100 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Antibodies to human immunodeficiency virus (HIV-1) in autoimmune diseases: primary Sjögren's syndrome, systemic lupus erythematosus, rheumatoid arthritis and autoimmune thyroid diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Detection of cytomegalovirus and Epstein-Barr virus in labial salivary glands in Sjogren's syndrome and non-specific sialadenitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

New evidence for involvement of retroviruses in Sjögren's syndrome and other autoimmune diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Sialadenitis histologically resembling Sjogren syndrome in mice transgenic for hepatitis C virus envelope genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

HCV and Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Hepatitis C virus and Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

[Sicca syndrome and hepatitis C virus infection: a Gougerot-Sjögren pseudo-syndrome?]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Immunohistochemistry of minor salivary gland biopsy specimens from patients with Sjögren's syndrome with and without hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Focal lymphocytic aggregates in chronic hepatitis C: Occurrence, immunohistochemical characterization, and relation to markers of autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Sicca syndrome associated with hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Gougerot-Sjögren, syndrome sec et hépatite C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Hepatitis C virus infection in 'primary' Sjögren's syndrome: prevalence and clinical significance in a series of 90 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Chronic lymphocytic sialoadenitis in HCV-related chronic liver disease: comparison of Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Absence of hepatitis C viral infection among patients with primary Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Extrahepatic manifestations of chronic hepatitis C infection and the interrelationship between primary Sjögren's syndrome and hepatitis C in Swedish patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Mild sialoadenitis: a common finding in patients with hepatitis C virus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Sjögren's syndrome and hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Extrahepatic manifestations of hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Hepatitis C virus infection, Sjögren's syndrome, and non-Hodgkin's lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Hepatitis C virus infection in patients with Sjögren's syndrome and non-Hodgkin's lymphoma: comment on the article by Voulgarelis et al.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

In Situ Detection of Hepatitis C Virus RNA in Salivary Glands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Hepatitis C virus infection mimicking primary Sjögren syndrome. A clinical and immunologic description of 35 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Hepatitis C virus and Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Immunologic features and HLA associations in chronic viral hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Autoantibodies and response to alpha-interferon in patients with chronic viral hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Virus-induced autoimmunity in hepatitis C virus infections: a rare event

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Cryoglobulinaemia and hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Hepatitis C virus infection in patients with essential mixed cryoglobulinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Mixed cryoglobulinemia: new concepts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Hepatitis C virus infection in non-Hodgkin's B-cell lymphoma complicating mixed cryoglobulinaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Cardiovascular risk factors and the long-term outcome of lupus nephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Systemic lupus erythematosus in men: clinical and immunological characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Systemic lupus erythematosus in the elderly: clinical and immunological characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Infections, idiotypes and SLE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Polyarteritis nodosa and hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Hepatitis C virus antibodies in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Hepatitis B and C viruses serology in patients with SLE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Prevalence of hepatitis C virus antibody in patients with systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Increased incidence of anti-cardiolipin antibodies in patients with hepatitis C is not associated with aetiopathogenetic link to anti-phospholipid syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Hepatitis C virus infection mimicking systemic lupus erythematosus: study of hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Systemic lupus erythematosus preceded by long-term cryoglobulinaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

A case of systemic lupus erythematosus or hepatitis C virus?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Hepatitis C as another possible cause of porphyria cutanea tarda and systemic lupus erythematosus: comment on the article by Kutz and Bridges.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Hepatitis C virus infection and autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Possible Association between Behçet's Syndrome and Chronic Hepatitis C Virus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Cardiogenic shock following recombinant alpha-2b interferon therapy for chronic hepatitis C. A case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

A patient with chronic hepatitis C who simultaneously developed interstitial pneumonia, hemolytic anemia and cholestatic liver dysfunction after alpha-interferon administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Chronic hepatitis C complicated by Coombs-negative hemolytic anemia during interferon treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

MALT non-Hodgkin's lymphoma associated with hepatitis C virus infection treated by interferon alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Thrombocytopenia associated with hepatitis C viral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Prevalence and significance of anticardiolipin, anti-beta2 glycoprotein I and anti-prothrombin antibodies in chronic hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Lupus anticoagulant, anticardiolipin antibodies and hepatitis C virus infection in thalassaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Anticardiolipin antibodies in patients with liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Anticardiolipin antibodies in patients with chronic hepatitis C virus infection: characterization in relation to antiphospholipid syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Clinical associations between arthritis and liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

True positive anti-HCV tests in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Polyarthritis associated with hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

A case of hepatitis C virus (HCV)-associated arthritis. Quantitative analysis of HCV RNA of the synovial fluid and the serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Fibromyalgia-associated hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Development of Rheumatoid Arthritis after Chronic Hepatitis Caused by Hepatitis C Virus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Inflammatory myopathy and hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Polymyositis, pulmonary fibrosis, and hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Symptomatic myopathy in hepatitis C infection without interferon therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Hepatitis C infection and polymyositis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Dermatomyositis, hepatocarcinoma, and hepatitis C: comment on the article by Weidensaul et al

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Polymyositis, lung fibrosis, and cranial neuropathy in a patient with hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Symptomatic myopathy associated with interferon therapy for chronic hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

[Periarteritis nodosa disclosed by epilepsy in a drug addict with hepatitis B and C virus carrier state]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Spontaneous perirenal hemorrhage after rupture of an aneurysm in case of polyarteritis nodosa along with anuric renal failure. Case report and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

HLA-B27 positive ankylosing spondylitis and polyarteritis nodosa: a case report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

False-positive anti-HCV tests in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

More on hepatitis C virus and Behçet's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Prevalences of hepatitis A, B, C and E viruses in Behçet's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Urticarial vasculitis with papular lesions in a patient with type C hepatitis and cryoglobulinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Hypocomplementaemic urticarial vasculitis, interstitial lung disease and hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Hepatitis C and mixed cryoglobulinaemia: a case of primary gastrointestinal necrotising vasculitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Successful treatment of severe hepatitis C-associated pulmonary vasculitis in a liver transplant recipient.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Prevalence of antibodies to hepatitis C virus in sera from patients with systemic necrotizing vasculitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

Vasculitis with hepatitis B antigenemia: long-term observation in nine patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Adult Still's disease associated with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2801%2971958-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-7753(01)71958-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11412684%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference